Which has grown faster, CELU or RANI?

Over the past five years, RANI grew revenue faster — CELU at a 8.31% CAGR versus RANI at 9.95%.

How have CELU and RANI total returns compared?

Over the past 5 years, CELU delivered -52.57% and RANI delivered -46.70% annualized total return. Past performance doesn't predict future results.

Celularity Inc. (CELU) vs Rani Therapeutics Holdings, Inc. (RANI)

A side-by-side comparison of Celularity Inc. and Rani Therapeutics Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CELU

Celularity Inc.

$51M

$1.76HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT

RANI

Rani Therapeutics Holdings, Inc.

$51M

$0.79HealthcareDelayed quote: Oct 6, 2026, 12:23 PM EDT

Total return — CELU vs RANI

growth of $100 · dividends reinvested · last 5y

CELU -98.1% (-54.5%/yr)RANI -93.0% (-41.2%/yr)RANI compounded faster over this window

CELU RANI

CELU vs RANI: by the numbers

•RANI is the larger company ($51M vs $51M market cap).
•Both run net losses; CELU's is the smaller (-375.77% vs -618.02% net margin).
•RANI grew revenue faster over the past five years (9.95% vs 8.31% CAGR).

Metrics side by side

Valuation

Metric	CELU	RANI
P/S ratio	2.68	10.52
P/B ratio	N/A	1.31

Profitability

Metric	CELU	RANI
Gross margin	79.62%	44.89%
Operating margin	-230.92%	-2345.99%
Net margin	-375.77%	-618.02%
ROE	N/A	-76.82%
ROIC	-192.99%	-63.96%

Growth (annualized)

Metric	CELU	RANI
Revenue CAGR (5Y)	8.31%	9.95%
Total return CAGR (5Y)	-52.57%	-46.70%

Frequently asked

Which has grown faster, CELU or RANI?: Over the past five years, RANI grew revenue faster — CELU at a 8.31% CAGR versus RANI at 9.95%.
How have CELU and RANI total returns compared?: Over the past 5 years, CELU delivered -52.57% and RANI delivered -46.70% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CELU analysis Full RANI analysis Interactive comparison tool

Dig into the metrics

Celularity ROE Rani Therapeutics ROE Celularity operating margin Rani Therapeutics operating margin Celularity revenue growth Rani Therapeutics revenue growth Celularity free cash flow Rani Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.